IP Due Diligence for Biotech: Evaluating Innovation, Risk and Value

​Join us for "IP Due Diligence for Biotech: Evaluating Innovation, Risk and Value", where we'll explore how biotech startups can build and protect their IP, manage collaboration risks, and maximise long-term value—while understanding what investors look for during IP due diligence.

​This session examines IP due diligence from both sides of the transaction—the startup seeking investment and the investor evaluating innovation.

​Whether you're a founder, researcher, investor or part of the life sciences ecosystem, join us for an engaging discussion on how robust IP strategies can strengthen innovation, mitigate risk and unlock long-term value.